<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03900897</url>
  </required_header>
  <id_info>
    <org_study_id>G180269</org_study_id>
    <nct_id>NCT03900897</nct_id>
    <nct_alias>NCT04130113</nct_alias>
  </id_info>
  <brief_title>Expanded Indications in the MED-EL Pediatric Cochlear Implant Population</brief_title>
  <official_title>Expanded Indications in the MED-EL Pediatric Cochlear Implant Population</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Med-El Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Med-El Corporation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this investigation is to demonstrate the safety and effectiveness of MED‐EL
      cochlear implants in children 7 months to 5 years, 11 months of age who fall outside the
      current FDA‐approved candidacy criteria and, yet, continue to demonstrate insufficient
      functional access to sound with appropriately fit hearing aids and aural habilitation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 17, 2019</start_date>
  <completion_date type="Anticipated">July 2022</completion_date>
  <primary_completion_date type="Anticipated">July 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Score on LittlEARS Auditory Questionnaire (LEAQ)</measure>
    <time_frame>Up to 12 Months Post-Activation</time_frame>
    <description>Clinical success defined as a Total Score of 25 or more on the LittLEARS Auditory Questionnaire (LEAQ). Total Score ranges from zero to 35, with higher scores indicating development of increasingly complex listening skills.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Percent correct on Multisyllabic Lexical Neighborhood Test (MLNT)/Lexical Neighborhood Test (LNT)</measure>
    <time_frame>Up to 12 Months Post-Activation</time_frame>
    <description>Clinical success defined as an improvement of 10 percentage points or more on MLNT/LNT.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number and proportion of subjects experiencing device- and/or procedure-related adverse events.</measure>
    <time_frame>Up to 12 Months Post-Activation</time_frame>
    <description>Adverse events will be collected and reported throughout the duration of the study.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total Score on LittlEARS Auditory Questionnaire (LEAQ)</measure>
    <time_frame>Up to 12 Months Post-Activation</time_frame>
    <description>Change from baseline in Total Score on the LittlEARS Auditory Questionnaire (LEAQ). Total Score ranges from zero to 35, with higher scores indicating development of increasingly complex listening skills. The LittlEARS Auditory Questionnaire is intended for young children with zero to 24 months of listening experience.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Score on Auditory Skills Checklist (ASC)</measure>
    <time_frame>Up to 12 Months Post-Activation</time_frame>
    <description>Change from baseline in Total Score on the Auditory Skills Checklist (ASC). Total Score ranges from zero to 70, with higher scores indicating development of increasingly complex listening skills. The Auditory Skills Checklist is intended for children from zero to 18 years of age.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Speech recognition testing in the implanted ear(s)</measure>
    <time_frame>Up to 12 Month Post-Activation</time_frame>
    <description>Percent change from baseline scores on speech recognition testing with words in quiet and sentences in quiet and noise.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Hearing Loss, Sensorineural</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MED-EL SYNCHRONY PIN Cochlear Implant</intervention_name>
    <description>Subjects will be implanted with the MED-EL SYNCHRONY PIN Cochlear Implant System with +FLEX24, +FLEX28, +FLEXSOFT electrode arrays. Subjects will be fit with the SONNETEAS (ear-level) and/or RONDO 2 (single-unit) external audio processors.</description>
    <other_name>SYNCHRONY +FLEXSOFT</other_name>
    <other_name>SYNCHRONY +FLEX28</other_name>
    <other_name>SYNCHRONY +FLEX24</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children 7 months to 5 years 11 months of age at the time of implantation

          -  Bilateral, severe to profound sensorineural hearing loss (SNHL) in the high
             frequencies and

               -  For subjects implanted under 12 months of age: bilateral, severe to profound SNHL
                  in the low frequencies

               -  For subjects implanted at 12 months to 5 years 11 months of age: bilateral, mild
                  to profound sensorineural hearing loss in the low frequencies

          -  Insufficient functional access to sound with appropriately fit amplification and aural
             habilitation

          -  Objective measures consistent with repeatable unaided audiometric thresholds for
             subjects under 12 months of age

          -  Radiologic evidence of potential for full insertion with one of the included electrode
             arrays

          -  Ability to undergo general anesthesia

          -  At least one parent/guardian who is fluent in one of the available languages of the
             LEAQ

          -  Parental commitment to study parameters

        Exclusion Criteria:

          -  Magnetic Resonance Imaging (MRI) evidence of cochlear nerve deficiency

          -  Active middle ear infection

          -  Permanent conductive hearing loss

          -  Treatable mixed hearing loss

          -  Current or history of meningitis

          -  Common cavity

          -  Skin or scalp condition precluding use of external audio processor

          -  Suspected cognitive impairment, organic brain dysfunction, or syndromic etiology that
             may affect performance

          -  ASA (American Society of Anesthesiologists) Class 3 or higher in subjects under 12
             months of age

          -  History of prior use of a hearing implant

          -  Unrealistic parental/patient expectations

          -  Child is not able to complete speech perception testing in English
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>7 Months</minimum_age>
    <maximum_age>6 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Miami Health System</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ivette Cejas, PhD</last_name>
      <phone>305-243-9199</phone>
      <email>ICejas@med.miami.edu</email>
    </contact>
    <contact_backup>
      <last_name>Christina Sarangoulis</last_name>
      <phone>305-243-8397</phone>
      <email>cmd247@med.miami.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Ivette Cejas, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ann &amp; Robert H. Lurie Children's Hospital of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nancy Young, MD</last_name>
      <phone>312-227-3075</phone>
      <email>NYoung@luriechildrens.org</email>
    </contact>
    <contact_backup>
      <last_name>Denise Thomas, AuD</last_name>
      <phone>312-227-3075</phone>
      <email>dthomas@luriechildrens.org</email>
    </contact_backup>
    <investigator>
      <last_name>Nancy Young, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Denise Thomas, Au.D,CCC-A</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Mississippi Medical Center</name>
      <address>
        <city>Jackson</city>
        <state>Mississippi</state>
        <zip>39216</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jeffrey Carron, MD</last_name>
      <phone>601-984-5162</phone>
      <email>jcarron@umc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Victoria Gonzalez, AuD, PhD</last_name>
      <phone>601-984-5162</phone>
      <email>vgonzalez@umc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Jeffery Carron, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Victoria Gonzalez, AuD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of North Carolina Hospitals</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>27514</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lisa Park, AuD</last_name>
      <phone>919-966-8926</phone>
      <email>Lisa_Park@med.unc.edu</email>
    </contact>
    <investigator>
      <last_name>Lisa Park, AuD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>ENT for Children</name>
      <address>
        <city>Coppell</city>
        <state>Texas</state>
        <zip>75019</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Bauer, M.D.</last_name>
      <phone>972-745-8400</phone>
      <email>bauer@entforchildren.net</email>
    </contact>
    <contact_backup>
      <last_name>Janée Gisclair, M.A.</last_name>
      <phone>972-745-8400</phone>
      <email>gisclair@entforchildren.net</email>
    </contact_backup>
    <investigator>
      <last_name>Paul Bauer, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Janée Gisclair, M.A.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>April 1, 2019</study_first_submitted>
  <study_first_submitted_qc>April 1, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 3, 2019</study_first_posted>
  <last_update_submitted>February 25, 2020</last_update_submitted>
  <last_update_submitted_qc>February 25, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Hearing Loss, Sensorineural</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

